Perfuze
Perfuze is developing innovative medical technology to treat acute ischemic stroke.
Perfuze has raised €25M across 2 funding rounds from 6 investors, most recently a round in Mar 2025. Based in Newcastle, Ireland; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€25M
€25,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2019-01
latest 2025-03
Funding by year
EUR raised per yearPerfuze — funding by year — interactive chart.
Data table
| Perfuze — funding by year | |
|---|---|
| 2018 | €3.0M |
| 2025 | €22M |
Signals
High confidenceRaise-next likelihood43
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-13 | Other | €22M | Earlybird Venture Capital,EQT Life Sciences,Existing investors,Seroba,SV Health Investors | View deal → |
| 2019-01-01 | Seed | €3.0M | EarlyBirdCapital | View deal → |
Investors
6Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData